Novartis International AG

<
>
How to read and use this data card.
LOADING...
1717450
de04d5267cda489c98d48d77b457aa48

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

2,250,000€ - 2,499,999€

Financial year: 01/01/2018 - 01/12/2018

Lobbyists declared: 5.75 FTE (15)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.

5
0.75

Lobbyists with EP accreditation: 6

5
1

Meetings with European Commission: 21

Lobbying costs over the years:

1
5
10
100
1000

Novartis International AG

Registration on EU Transparency Register

91269481588-28 (First registered: 27 Apr 2009)

Goals / Remit

Our vision is to be a trusted leader in changing the practice of medicine. Our mission is to discover new ways to improve and extend people's lives. We use science-based innovation to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. We also aim to provide a shareholder return that rewards those who invest their money, time and ideas in our company.

Issues

Antimicrobial resistance (AMR) ATMP Regulation Big data Biosimilars & generics Clinical Trials Regulation Data Protection Regulation EU IP policy EU Relative Efficacy Assessment (EU REA) EU research policy EU trade policy Health Systems Performance Assessment Health Technology Assessment & Market Access Industrial policy Innovative Medicines Initiative (IMI) In-Vitro Diagnostic Regulation Medical Devices Regulation Outcomes-based healthcare systems Orphan Medicinal Products Regulation Paediatric Regulation Patient access to innovation Patient safety Pharmaceuticals in the environment Sustainable Development Goals

Address

Head office:
Novartis International AG Forum 1 Forum 1
Basel CH-4002,
Switzerland

Tel: 41 61 324 11 11

Belgium office:
Rue du Trône 108
Brussels ,
Belgium

Tel: 32 2 246 1975